JP2010120974A5 - - Google Patents

Download PDF

Info

Publication number
JP2010120974A5
JP2010120974A5 JP2010040362A JP2010040362A JP2010120974A5 JP 2010120974 A5 JP2010120974 A5 JP 2010120974A5 JP 2010040362 A JP2010040362 A JP 2010040362A JP 2010040362 A JP2010040362 A JP 2010040362A JP 2010120974 A5 JP2010120974 A5 JP 2010120974A5
Authority
JP
Japan
Prior art keywords
group
isoxazole
pyrimidinyl
acetylamino
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010040362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010120974A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010040362A priority Critical patent/JP2010120974A/ja
Priority claimed from JP2010040362A external-priority patent/JP2010120974A/ja
Publication of JP2010120974A publication Critical patent/JP2010120974A/ja
Publication of JP2010120974A5 publication Critical patent/JP2010120974A5/ja
Pending legal-status Critical Current

Links

JP2010040362A 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物 Pending JP2010120974A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010040362A JP2010120974A (ja) 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007035916 2007-02-16
JP2010040362A JP2010120974A (ja) 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008558013A Division JP4588791B2 (ja) 2007-02-16 2008-02-15 微粒子油性懸濁液を含む医薬組成物

Publications (2)

Publication Number Publication Date
JP2010120974A JP2010120974A (ja) 2010-06-03
JP2010120974A5 true JP2010120974A5 (https=) 2011-02-03

Family

ID=39689861

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008558013A Expired - Fee Related JP4588791B2 (ja) 2007-02-16 2008-02-15 微粒子油性懸濁液を含む医薬組成物
JP2010040362A Pending JP2010120974A (ja) 2007-02-16 2010-02-25 微粒子油性懸濁液を含む医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008558013A Expired - Fee Related JP4588791B2 (ja) 2007-02-16 2008-02-15 微粒子油性懸濁液を含む医薬組成物

Country Status (9)

Country Link
US (1) US8309138B2 (https=)
EP (1) EP2123255B1 (https=)
JP (2) JP4588791B2 (https=)
KR (1) KR101434706B1 (https=)
CN (1) CN101610754A (https=)
AU (1) AU2008215659B2 (https=)
CA (1) CA2677842C (https=)
ES (1) ES2423929T3 (https=)
WO (1) WO2008099615A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102176900B (zh) 2008-09-17 2017-09-26 克艾思马有限公司 药物组合物和相关的给药方法
CN103655512B (zh) * 2013-12-12 2015-05-20 海南海力制药有限公司 一种硝酸芬替康唑阴道软胶囊及其制备方法
HUE071943T2 (hu) 2015-02-03 2025-10-28 Amryt Endo Inc Akromegália kezelése oktreotid orális alkalmazásával
WO2019022152A1 (ja) 2017-07-26 2019-01-31 学校法人同志社 TGF-βシグナルに起因する障害を治療または予防するための医薬およびその応用
EP3668957A4 (en) * 2017-08-17 2021-06-02 University of Delaware Furan based compositions and methods of making thereof
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0548238A1 (en) 1990-09-13 1993-06-30 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
MX9300141A (es) 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
JPH0616556A (ja) 1992-07-02 1994-01-25 Yoshitomi Pharmaceut Ind Ltd 難溶性薬物含有製剤
US5651983A (en) 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5656290A (en) 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
JPH07138151A (ja) 1993-11-15 1995-05-30 Kanebo Ltd ソフトカプセル剤及びその製造方法
ES2183935T3 (es) 1995-02-13 2003-04-01 Searle & Co Isoxazoles sustituidos para el tratamiento de la inflamacion.
JPH1081621A (ja) 1996-04-01 1998-03-31 Takeda Chem Ind Ltd 経口投与用医薬組成物
RU2186562C2 (ru) 1996-08-22 2002-08-10 Ресеч Трайангл Фармасьютикалс Лтд. Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
US5736151A (en) 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
PL337020A1 (en) 1997-05-22 2000-07-31 Searle & Co Substituted pyrazoles as kinase p38 inhibitors
CA2320087C (en) 1998-02-09 2006-12-19 Joel Bolonick Treatment of chronic inflammatory disorders of the gastrointestinal tract
JPH11302156A (ja) 1998-04-16 1999-11-02 Tanabe Seiyaku Co Ltd ポリペプチドの微粒子化方法
JP4191825B2 (ja) 1998-09-10 2008-12-03 あすか製薬株式会社 5−アミノイソキサゾール誘導体
PE20001227A1 (es) 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
DE69911993T2 (de) * 1998-12-23 2004-05-19 Amgen Inc., Thousand Oaks Polyol/öl-suspensionen zur verzörgerten freisetzung von proteinen
AU765492B2 (en) 1998-12-25 2003-09-18 Teikoku Hormone Mfg. Co., Ltd. Aminopyrazole derivatives
JP2002534371A (ja) 1999-01-06 2002-10-15 コリア リサーチ インスティテュート オブ ケミカル テクノロジー 水不溶性薬物を含む医薬的活性成分の製造方法及びそれを含む経口投与用医薬組成物
EA004683B1 (ru) 1999-02-23 2004-06-24 Мерк Энд Ко., Инк. Фармацевтическая композиция, содержащая омепразол
WO2000064894A1 (en) 1999-04-23 2000-11-02 Takeda Chemical Industries, Ltd. 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
CA2386277A1 (en) 1999-10-01 2001-04-12 Natco Pharma Limited An improved pharmaceutical composition and a process for its preparation
IN192188B (https=) 2000-06-16 2004-03-13 Ranbaxy Lab Ltd
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
CA2423170A1 (en) 2000-09-22 2002-03-28 Galephar M/F Pharmaceutical semi-solid composition of isotretinoin
AU2002364146A1 (en) 2001-12-20 2003-07-09 Pharmacia Corporation Pharmaceutical suspension for oral administration
DE60319073T2 (de) 2002-03-20 2009-02-05 Elan Pharma International Ltd. Nanopartikelzusammensetzungen von mitogen-aktivierten protein (map) kinase inhibitoren
GB0214268D0 (en) 2002-06-20 2002-07-31 Celltech R&D Ltd Chemical compounds
CA2492112A1 (en) 2002-08-06 2004-02-19 F. Hoffmann-La Roche Ag 6-alkoxy-pyrido-pyrimidines as p-38 map kinase inhibitors
DE10237883A1 (de) 2002-08-19 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
AU2003255844A1 (en) 2002-08-23 2004-03-11 Ionix Pharmaceuticals Limited Five-membered heterocyclic compounds in the treatment of chronic and acute pain
JP2004099442A (ja) 2002-09-04 2004-04-02 Nisshin Pharma Inc 難溶性薬物含有製剤およびその製造方法
US20040132755A1 (en) 2002-09-06 2004-07-08 Mark Ledeboer Isoxazoles and uses thereof
PT1605956E (pt) 2002-12-18 2016-03-09 Centrexion Therapeutics Corp Administração de capsaicinóides para o tratamento da osteoartrite
PL378111A1 (pl) 2003-02-14 2006-03-06 Smithkline Beecham Corporation Nowe związki
CA2515190A1 (en) 2003-02-14 2004-08-26 Pfizer Products Inc. Triazolo-pyridines as anti-inflammatory compounds
JPWO2004073692A1 (ja) 2003-02-18 2006-06-01 山下 伸二 難水溶性薬物のハードカプセル剤
JP2005013938A (ja) 2003-06-27 2005-01-20 Canon Inc 脱色装置及び方法
WO2005013938A1 (ja) 2003-08-06 2005-02-17 Eisai Co., Ltd. 薬物超微粒子の製造法及び製造装置
JP5096658B2 (ja) 2003-10-06 2012-12-12 株式会社三協 生物学的利用能を向上させたソフトカプセル
GB0402143D0 (en) 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
KR100843526B1 (ko) 2004-02-27 2008-07-03 에프. 호프만-라 로슈 아게 피라졸의 접합 유도체
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
DK1742618T3 (da) 2004-05-04 2012-10-01 Hormos Medical Ltd Flydende orale formuleringer af ospemifen
AU2005320544B2 (en) 2004-12-28 2011-03-24 Aska Pharmaceutical Co., Ltd. Pyrimidinylisoxazol derivative
JP2007039408A (ja) 2005-08-05 2007-02-15 Unitec Foods Co Ltd 微粉化クレアチンとその製造方法

Similar Documents

Publication Publication Date Title
JP2010120974A5 (https=)
AU2014219283C1 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
RU2003114752A (ru) Лечение желудочно-кишечных стромальных опухолей
RU2439068C2 (ru) Модуляторы mglur5
JP2008505157A5 (https=)
JPWO2012144463A1 (ja) 腫瘍治療剤
JP2005519916A5 (https=)
JP2004512328A5 (https=)
JP2016512825A5 (https=)
JP2004534774A5 (https=)
JP2004517049A5 (https=)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
JP2017502068A5 (https=)
JP2012530765A5 (https=)
JP2017530187A5 (https=)
JP2007510665A5 (https=)
JP2007528379A5 (https=)
JP2020516671A5 (https=)
JP2007510689A5 (https=)
JP2005500363A5 (https=)
JP2010501478A5 (https=)
JP2011510055A5 (https=)
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2014502979A5 (https=)
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体